Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroUptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cellsMultidrug efflux pumps of gram-negative bacteriaMexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosaExpression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expressionRole of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosaCrystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end.Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa.Characterization of stress-responsive behavior in Pseudomonas aeruginosa PAO: isolation of Tn3-lacZYA fusions with novel damage-inducible (din) promoters.Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacinContribution of cell elongation to the biofilm formation of Pseudomonas aeruginosa during anaerobic respirationEfflux-mediated resistance to fluoroquinolones in gram-negative bacteriaBiofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?Significance of biocide usage and antimicrobial resistance in domiciliary environments.Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistanceContribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.Purification of a 54-kilodalton protein (OprJ) produced in NfxB mutants of Pseudomonas aeruginosa and production of a monoclonal antibody specific to OprJOprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosaDifferential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa.Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.Broad-host-range gyrase A gene probe.Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.Outer membrane barrier as a mechanism of antimicrobial resistance.Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureusA pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.Efflux-mediated antimicrobial resistance.Genetic mapping and characterization of Pseudomonas aeruginosa mutants defective in the formation of extracellular proteinsChromosomal mapping of mutations affecting glycerol and glucose catabolism in Pseudomonas aeruginosa PAOClustering of mutations affecting central pathway enzymes of carbohydrate catabolism in Pseudomonas aeruginosa.Proton-dependent multidrug efflux systems.Resistance to pefloxacin in Pseudomonas aeruginosa.Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance.
P2860
Q24670241-5F52C45C-FBDF-41A5-A34E-571C8EF5F181Q24676018-D63CB7FF-779C-4FCE-BBA4-BC3871936D5CQ24681708-C31C385B-89B6-40C7-8E96-6ADCB9803164Q28492497-F986CEB1-859C-45C4-97A2-707400E239E0Q28492704-8F36C4FB-EAAC-4081-90E6-EA56D2AFDD3FQ28492894-1B5A2121-07E1-4752-AD5F-504396227B2AQ28493072-8401A630-C5F5-4DAC-B7A2-6607A0CA8F2EQ30160421-63D4C2E5-35ED-4BAB-B953-309EB87A8DBAQ30341412-D91B85B5-F6A1-4945-B342-9FCD9C52952DQ31160230-BD32B736-FF86-43C1-97CA-725D3E6CD68BQ33756446-BA8CB7A1-DB0D-4832-9437-8C7EE0EAFF1CQ33803878-52D8C6A5-154B-41A7-B94B-155B607B19FDQ34010692-7465F121-7302-441F-AFB0-92E479B3C52FQ34631472-EE7DDDE7-D772-42E9-A2E6-8C276F0F5748Q34631484-1198564E-939F-44F6-A0B4-9AB32D8E1C4FQ34927172-2C424454-BA8F-4219-8B49-C896A6D5AA17Q35115957-DD752732-05E2-4FA9-8CFC-1CD60300228EQ35117101-269CF90C-CF72-4142-8816-8650C3100CE0Q35120124-0DC3A95C-F0C6-4056-BF66-D9FA882E1C07Q35139043-A66EB408-66D1-42F7-85E5-A9B1A9D3B0CBQ35244676-A5380AF6-92A1-4CFA-A21E-E6DCACC9E28FQ35276491-8CF9B71A-1DDF-43C5-9FA8-806CD02E8C43Q35291821-5C4DF7AC-61FF-4BEB-87F4-BEBB0C163BD3Q35299812-26F82287-1FA4-44AB-9B02-CDB541F3FCACQ35357625-1BA229E8-71EA-4A3D-AD6B-915DBEB08AAEQ35359592-E36BDD47-B1AB-4BD6-B432-4AA24499B8E5Q35640867-F8DEB075-DB84-430C-99A7-897E9D22A22DQ35650708-F2DB1D50-7040-424A-BBB5-38639D064E61Q35816058-28038840-34C2-4DEC-B043-0E293FD3ED17Q35836280-E119F9FD-D658-41AA-AD31-B22DA6EE6A04Q36123973-18C19437-8713-4607-9833-7095B61EED4BQ36138147-53E8390C-2C7F-4C3F-97B5-507680C598C9Q36300592-B667F9AB-9162-4DB9-97C4-32163F680D8AQ36305197-81B205F5-E720-4E16-80D6-38068A65096BQ36333445-C054B1A5-FCA2-4C97-859F-99D4B1F8D05EQ36672016-FCEC30EF-E1CF-4177-98E9-F72C993CFC68Q36753117-BD41068B-2E41-426C-A2EE-2C021631D99FQ36754434-76D94ABE-0AFB-43A7-98BC-5EBE145120E1Q37119995-3BDA1646-6E08-4010-AC6B-07752C7B40E3Q38049220-67666BC6-E5AC-4320-8E93-5F9816EC4AD1
P2860
Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@en
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@nl
type
label
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@en
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@nl
prefLabel
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@en
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@nl
P2860
P356
P1476
Resistance of Pseudomonas aeru ...... mapping of chromosomal genes.
@en
P2860
P304
P356
10.1128/AAC.22.2.242
P407
P577
1982-08-01T00:00:00Z